Phibro Animal Health | PAHC - Stock


Phibro Animal Health reported $539.7M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Align Technology USD 214.94M 11.4M Mar/2026
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Assertio Holdings USD 24.76M 8.12M Sep/2025
Aurora Cannabis CAD 230.56M 8.6M Dec/2025
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Canopy Growth CAD 105.56M 3.18M Dec/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Henry Schein USD 2.01B 12M Mar/2026
Idexx Laboratories USD 382.4M 4.64M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Merck USD 6.48B 179M Mar/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Pacira USD 150.37M 2.49M Mar/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Prestige Brands USD 163.59M 4.6M Dec/2025
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Zoetis USD 2.55B 120M Mar/2026